Epigenetics
-
CUDC-907 (Fimepinostat)
Catalog No. A11153 PI3K/HDAC 抑制剂CUDC-907 (Fimepinostat)是针对PI3K和HDAC的单一小分子抑制剂,作用于PI3Kα和HDAC1/2/3/10,IC50分别为19 nM和1.7 nM/5 nM/1.8 nM/2.8 nM。 了解更多 -
Parthenolide ((-)-Parthenolide)
Catalog No. A10698 Parthenolide ((-)-Parthenolide), Nuclear Factor-κB抑制剂,可特异性地耗尽HDAC1蛋白,而不影响其他I/II类 HDACs。促进MDM2的泛素化并激活p53的细胞功能。 了解更多 -
LAQ824 (NVP-LAQ824, Dacinostat)
Catalog No. A10516 HDAC 抑制剂LAQ824 (NVP-LAQ824)是一种有效的新型组蛋白去乙酰化酶抑制剂,具有显著的抗多发性骨髓瘤活性。 了解更多 -
ACY-1215 (Rocilinostat)
Catalog No. A11940 HDAC6 抑制剂ACY-1215 (Rocilinostat)是一种选择性HDAC6抑制剂,从而通过Hsp90的超乙酰化作用破坏Hsp90蛋白伴侣系统,并防止随后的总蛋白降解。 了解更多 -
CI994 (Tacedinaline)
Catalog No. A11964 -
Romidepsin (FK228 ,Depsipeptide)
Catalog No. A11920 HDAC 抑制剂Romidepsin (FK228,Depsipeptide)抑制HDAC1和HDAC2,IC50分别为1.6 nM和3.9 nM,但相对较弱地分别抑制HDAC4和HDAC6,IC50值为25 nM和79 nM。 了解更多 -
RGFP966
Catalog No. A13218 -
Resminostat
Catalog No. A12556 HDAC 抑制剂Resminostat,也称为RAS2410,是一种有效的I和II类组蛋白脱乙酰基酶(HDAC)抑制剂。它结合并抑制HDAC,从而导致高度乙酰化的组蛋白的积累。选择性的抑制HDAC1/3/6,IC50为42.5 nM/50.1 nM/71.8 nM,作用于HDAC8效果弱,IC50为877 nM。 了解更多 -
RG2833 (RGFP109)
Catalog No. A13139 -
BRD73954
Catalog No. A15489 -
Resminostat hydrochloride
Catalog No. A15220 HDAC 抑制剂Resminostat hydrochloride是HDAC1/3/6的有效抑制剂(IC50 = 43-72 nM);对HDAC8的效力较低,IC50为877 nM。 了解更多 -
KD 5170
Catalog No. A15354 -
Citarinostat (ACY-241)
Catalog No. A12758 HDAC6 抑制剂ACY-241是HDAC6的新型,选择性和口服抑制剂。对HDAC6和HDAC3的IC50分别为2.6 nM和46 nM。 了解更多 -
CRA-026440
Catalog No. A12179 -
Valproic acid sodium salt
Catalog No. A10855 HDAC inhibitorValproic acid sodium salt (Sodium Valproate) is an HDAC inhibitor, with IC50 in the range of 0.5 and 2 mM, also inhibits HDAC1 (IC50, 400 μM), and induces proteasomal degradation of HDAC2. 了解更多 -
JAK/HDAC-IN-1
Catalog No. A13362 JAK2/HDAC dual inhibitorJAK/HDAC-IN-1 is a potent JAK2/HDAC dual inhibitor, exhibits antiproliferative and proapoptotic activities in several hematological cell lines. 了解更多 -
Sodium phenylbutyrate
Catalog No. A16714 HDAC/ER stress inhibitorSodium phenylbutyrate is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research. 了解更多 -
Tubastatin A
Catalog No. A16770 HDAC6 inhibitorTubastatin A is a potent and selective HDAC6 inhibitor with IC50 of 15 nM in a cell-free assay, and is selective (1000-fold more) against all other isozymes except HDAC8 (57-fold more). 了解更多 -
Givinostat
Catalog No. A21126 HDAC inhibitorGivinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. 了解更多 -
Givinostat hydrochloride
Catalog No. A21487 HDAC inhibitorGivinostat hydrochloride (ITF-2357 hydrochloride) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. 了解更多 -
Nanatinostat
Catalog No. A21625 HDAC inhibitorNanatinostat (CHR-3996) is a potent, class I selective and orally active histone deacetylase (HDAC) inhibitor with an IC50 of 8 nM. 了解更多 -
Belinostat
Catalog No. A21772 HDAC inhibitorBelinostat (PXD101; PX105684) is a potent HDAC inhibitor with an IC50 of 27 nM in HeLa cell extracts. 了解更多 -
HDAC-IN-5
Catalog No. A20972 -
Domatinostat tosylate
Catalog No. A20986 HDAC1 inhibitorDomatinostat tosylate (4SC-202) is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57 μM for HDAC1, HDAC2, and HDAC3, respectively. It also displays inhibitory activity against Lysine specific demethylase 1 (LSD1). 了解更多 -
Tefinostat
Catalog No. A20258 pan HDAC inhibitorTefinostat (CHR-2845) is a monocyte/macrophage-targeted pan HDAC inhibitor, cleaved into active acid CHR-2847 by the intracellular esterase human carboxylesterase-1 (hCE-1). Anti-monocytoid lineage leukaemias activity. 了解更多 -
Oxamflatin
Catalog No. A20265 HDAC inhibitorOxamflatin (Metacept-3) is a potent HDAC inhibitor with an IC50 of 15.7 nM. 了解更多